(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.32%) $78.73
(-1.46%) $2.16
(-0.02%) $2 330.70
(-0.25%) $27.55
(0.63%) $971.00
(0.08%) $0.929
(0.12%) $10.84
(0.07%) $0.797
(0.01%) $91.35
Live Chart Being Loaded With Signals
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering...
Stats | |
---|---|
本日の出来高 | 3.56M |
平均出来高 | 28 680.00 |
時価総額 | 309.26M |
EPS | £0 ( 2024-03-11 ) |
次の収益日 | ( £0 ) 2024-06-21 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -10.24 |
ATR14 | £0 (0.00%) |
MaxCyte Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
MaxCyte Inc 財務諸表
Annual | 2023 |
収益: | £41.29M |
総利益: | £36.55M (88.51 %) |
EPS: | £-0.370 |
FY | 2023 |
収益: | £41.29M |
総利益: | £36.55M (88.51 %) |
EPS: | £-0.370 |
FY | 2022 |
収益: | £44.26M |
総利益: | £39.16M (88.48 %) |
EPS: | £-0.190 |
FY | 2021 |
収益: | £33.89M |
総利益: | £30.25M (89.24 %) |
EPS: | £-0.210 |
Financial Reports:
No articles found.
MaxCyte Inc
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。